Panagora Asset Management Inc Fortress Biotech, Inc. Transaction History

Panagora Asset Management Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 10, 2021	SELL	$2.82 - $3.7 $7,721 - $10,130	-2,738 Closed	0 $0
Q2 2021 Aug 11, 2021	SELL	$3.5 - $5.48 $19,796 - $30,994	-5,656 Reduced 67.38%	2,738 $10,000
Q1 2021 May 12, 2021	SELL	$3.16 - $4.89 $1,292 - $2,000	-409 Reduced 4.65%	8,394 $30,000
Q4 2020 Feb 10, 2021	SELL	$2.2 - $4.45 $830,187 - $1.68 Million	-377,358 Reduced 97.72%	8,803 $28,000
Q3 2020 Nov 13, 2020	BUY	$2.62 - $4.78 $317,496 - $579,249	121,182 Added 45.73%	386,161 $1.56 Million

Q2 2020 Aug 12, 2020	BUY	$1.83 - $3.16 $484,911 - $837,333	264,979 New	264,979 $710,000

1.01M

Ticker FBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,735,000
Market Cap $189M
Description
Fortress Biotech, Inc., a biopharmaceutical company, develops and commercializes pharmaceutical and biotechnology products. The company markets dermatology products, such as Ximino capsules to treat only inflammatory lesions of non-nodular moderate to severe acne vulgaris; Targadox for severe acne; Exelderm cream for ringworm and jock itch sympt...

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Panagora Asset Management Inc with notifications on news.